NO955085L - Androstansteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder - Google Patents

Androstansteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder

Info

Publication number
NO955085L
NO955085L NO955085A NO955085A NO955085L NO 955085 L NO955085 L NO 955085L NO 955085 A NO955085 A NO 955085A NO 955085 A NO955085 A NO 955085A NO 955085 L NO955085 L NO 955085L
Authority
NO
Norway
Prior art keywords
steroids
pharmaceutical compositions
androstone
methods
change
Prior art date
Application number
NO955085A
Other languages
English (en)
Other versions
NO955085D0 (no
NO309926B1 (no
Inventor
David Berliner
Nathan William Adams
Clive L Jennings-White
Original Assignee
Pherin Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Corp filed Critical Pherin Corp
Publication of NO955085D0 publication Critical patent/NO955085D0/no
Publication of NO955085L publication Critical patent/NO955085L/no
Publication of NO309926B1 publication Critical patent/NO309926B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
NO955085A 1993-06-15 1995-12-14 Farmasøytisk blanding egnet for nasal administrering, forbindelse og anvendelse derav NO309926B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7735993A 1993-06-15 1993-06-15
PCT/US1993/009349 WO1994028904A1 (en) 1993-06-15 1993-09-28 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods

Publications (3)

Publication Number Publication Date
NO955085D0 NO955085D0 (no) 1995-12-14
NO955085L true NO955085L (no) 1996-02-14
NO309926B1 NO309926B1 (no) 2001-04-23

Family

ID=22137596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955085A NO309926B1 (no) 1993-06-15 1995-12-14 Farmasøytisk blanding egnet for nasal administrering, forbindelse og anvendelse derav

Country Status (14)

Country Link
EP (2) EP0711169B1 (no)
JP (1) JP3705806B2 (no)
AT (1) ATE255898T1 (no)
BG (1) BG63452B1 (no)
BR (1) BR9307867A (no)
CA (1) CA2165325A1 (no)
DE (1) DE69333352T2 (no)
ES (1) ES2210243T3 (no)
FI (1) FI956029A (no)
HU (1) HUT74172A (no)
NO (1) NO309926B1 (no)
NZ (1) NZ257218A (no)
PL (1) PL183582B1 (no)
WO (1) WO1994028904A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5994333A (en) * 1994-08-04 1999-11-30 Pherin Corporation Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
EP0858505B1 (en) * 1995-10-19 2004-12-29 The Trustees Of Columbia University In The City Of New York Cloning of vertebrate pheromone receptors and uses thereof
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
ES2273374T3 (es) * 1996-07-23 2007-05-01 Pherin Pharmaceuticals, Inc. Esteroides como estimuladores neuroquimicos del ovn para aliviar los sintomas de pms.
US6093389A (en) * 1997-12-01 2000-07-25 American Cyanamid Company Methods and compositions for attracting and controlling termites
US6544971B1 (en) * 2000-02-04 2003-04-08 Pherin Pharmaceuticals, Inc. Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
US6919337B2 (en) 2000-04-07 2005-07-19 Novartis, Ag 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
US7019136B2 (en) 2000-04-07 2006-03-28 Novartis, Ag 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
EP1234540B1 (en) * 2000-07-05 2007-03-21 Matsushita Electric Industrial Co., Ltd. Apparatus for screening,
US10322138B2 (en) 2012-12-28 2019-06-18 Pherin Pharmaceuticals, Inc. Treatment of depressive disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB765509A (en) * 1954-02-04 1957-01-09 Pfizer & Co C Improvements in or relating to steroids and the preparation thereof
FR7725M (no) * 1967-06-22 1970-03-02
GB1267514A (en) * 1968-07-23 1972-03-22 Nat Res Dev Improvements relating to artificial insemination of pigs
DE2345376A1 (de) * 1973-09-06 1975-03-20 Schering Ag Pharmazeutische zubereitung ii
GB1550343A (en) * 1975-07-16 1979-08-15 Gist Brocades Nv Androstane derivatives
DE2758549A1 (de) * 1977-12-23 1979-07-05 Schering Ag Pharmazeutische zubereitung
US5155045A (en) * 1985-01-25 1992-10-13 Trustees Of The University Of Penn. Use of male essence to alter female endocrine response
DD251077A1 (de) * 1986-07-21 1987-11-04 Adw Ddr Mittel zur anregung der brunstreaktion bei schweinen
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5208227A (en) * 1987-08-25 1993-05-04 University Of Southern California Method, compositions, and compounds for modulating brain excitability
FR2622194B1 (fr) * 1987-10-27 1990-03-23 Theramex Laboratoire Nouveaux derives de la 19-nor progesterone, leur procede d'obtention et les compositions pharmaceutiques en contenant
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
DK0614463T3 (da) * 1991-11-22 2003-03-31 Alcon Lab Inc Angiostatiske steroider
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones

Also Published As

Publication number Publication date
BG100286A (bg) 1997-02-28
NO955085D0 (no) 1995-12-14
CA2165325A1 (en) 1994-12-22
JP3705806B2 (ja) 2005-10-12
EP1340502A2 (en) 2003-09-03
BR9307867A (pt) 1996-07-30
FI956029A (fi) 1996-02-14
DE69333352T2 (de) 2004-07-22
ATE255898T1 (de) 2003-12-15
JPH09501409A (ja) 1997-02-10
EP0711169A4 (en) 2000-05-31
AU691474B2 (en) 1998-05-21
HU9503578D0 (en) 1996-02-28
NO309926B1 (no) 2001-04-23
EP1340502A3 (en) 2004-01-21
EP0711169A1 (en) 1996-05-15
AU5350494A (en) 1995-01-03
NZ257218A (en) 1998-07-28
PL183582B1 (pl) 2002-06-28
WO1994028904A1 (en) 1994-12-22
DE69333352D1 (de) 2004-01-22
ES2210243T3 (es) 2004-07-01
BG63452B1 (bg) 2002-02-28
HUT74172A (en) 1996-11-28
EP0711169B1 (en) 2003-12-10
PL312279A1 (en) 1996-04-15
FI956029A0 (fi) 1995-12-14

Similar Documents

Publication Publication Date Title
CA2223397A1 (en) Novel nor-pregnanes for inducing hypothalamic effects
NO955085L (no) Androstansteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder
DE69003015D1 (de) Behandlung von Störungen in der Postmenopause.
NO955084L (no) Estrensteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder
CA2258177A1 (en) 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
NO990305D0 (no) Steroider som neurokjemiske stimulatorer av VNO for Õ lindre symptomer av PMS og angst
MX9702253A (es) Nuevos estrenos para inducir efectos hipotalamicos
MX9700881A (es) Pregnanos y colanos como indicadores neuroquimicos del cambio en la funcion hipotalamica.
MXPA94000705A (es) Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana ycomposiciones farmaceuticas y metodos relacionados.
BR9816142A (pt) Esteróides de 19-nor-colano como iniciadores neuroquìmicos de mudança na função hipotalâmica humana
ATE157670T1 (de) Digitoxigenin und dihydrodigitoxigenin 3-beta- derivate und pharmazeutische präparate davon, zur behandlung von hypertonie
TW289730B (en) Pharmaceutical composition for alleviating the symptoms of psychoses, depression or anxiety comprising androstene steroids
IL108155A0 (en) Pharmaceutical compositions containing 17 alphadihydroequilenin or an ester or salt thereof
HUP0203655A2 (hu) Telítetlen 14,15-ciklopropano-androsztánok, előállításukat szolgáló eljárás és ezen vegyületeket tartalmazó gyógyszerészeti készítmények

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MARCH 2003